RxDoctor Payments Data

Christine Johnson

Nurse Practitioner · Saint Louis, MONPI 1225548225

Payments from drug & device makers

$842in general payments, 2019–2025

Across 38 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$196
  • Novo Nordisk$170
  • Pfizer$103
  • Radius Health, Inc.$94
  • GSK$71
  • Boehringer Ingelheim$50
  • plus $157 from 6 others

What the payments were for

  • Food & beverage$842100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$842 in reported general payments places this provider in the 75th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$32,325
Medicare patients
173
Services billed
687

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$69,552
MounjaroTirzepatide23$42,361
WegovySemaglutide12$16,008
EliquisApixaban20$11,461
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,062
Breo ElliptaFluticasone/Vilanterol18$7,073
Cyclobenzaprine Hcl41$750
Atorvastatin Calcium101$672
Levothyroxine Sodium57$582
Ezetimibe12$552
Gabapentin29$504
Metformin Hcl31$503
Losartan Potassium61$485
Bupropion XlBupropion Hcl11$472
Fluticasone Propionate20$434

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$170$85,55965 claims
Lilly USA, LLCMounjaro$196$42,36123 claims
GSKTrelegy Ellipta, Breo Ellipta$71$17,13533 claims
PfizerEliquis$103$11,46120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →